Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis
โ Scribed by Takayoshi Nishino; Hiroyasu Oyama; Etsuko Hashimoto; Fumitake Toki; Itaru Oi; Makio Kobayashi; Keiko Shiratori
- Publisher
- Springer Japan
- Year
- 2007
- Tongue
- English
- Weight
- 737 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
1. Recurrent primary sclerosing cholangitis (PSC) is extremely difficult, if not impossible, to distinguish from other causes of biliary strictures or sclerosing cholangitis in allografts using needle biopsy evaluation alone. Technical problems with biliary reconstruction, long cold ischemic times,
Hypertrophic osteoarthropathy has rarely been reported in children (1). Chronic lung disease has been the most commonly reported association in those series described during the preantibiotic era (1,2). Congenital cyanotic heart disease, biliary atresia, liver cirrhosis, metastatic lung tumor, and i
Primary sclerosing cholangitis (PSC) is a chronic fibroinflammatory syndrome involving the biliary tract, often accompanied by inflammatory bowel disease (IBD). This syndrome is a prototype disease linking chronic inflammation to carcinogenesis. Indeed, PSC is associated with an increased risk of ch
Recently, the autoimmune hepatitis (AIH)/primary sclerosing cholangitis (PSC) overlap syndrome has been reported increasingly. In this syndrome, patients present with features of both AIH and PSC. It has been suggested that the 2 diseases may be sequential in their occurrence, whereby patients have